Skip to main content

Table 2 GRADE evidence profile

From: The effects of medicinal and food homologous substances on blood lipid and blood glucose levels and liver function in patients with nonalcoholic fatty liver disease: a systematic review of randomized controlled trials

Outcomes

Certainty assessment

Effect

Certainty

No. of Studies

No. of Individuals

Rate (95%CI)

TC

Not serious

Very serious

Not serious

Not serious

Not serious

Large effect

9RCTs

629

MD: -21.76 (-33.73 to -9.79)

Moderate

TGs

Not serious

Very serious

Not serious

Not serious

Not serious

Large effect

9RCTs

629

MD:-26.51 (-41.23 to -11.78)

Moderate

LDL-C

Not serious

Very serious

Not serious

Not serious

Not serious

Large effect

9RCTs

629

MD:-16.13 (-25.91 to -6.34)

Moderate

HDL-C

Not serious

Serious

Not serious

Not serious

Not serious

Large effect

9RCTs

629

MD:3.26 (1.28 to 5.25)

High

FBG

Not serious

Very serious

Not serious

Not serious

Not serious

None

9RCTs

599

MD:-4.41 (-12.42 to 3.60)

Low

AST

Not serious

Very serious

Not serious

Not serious

Not serious

None

9RCTs

583

MD:-4.41 (-12.42 to 3.60)

Low

ALT

Not serious

Very serious

Not serious

Not serious

Not serious

Large effect

9RCTs

584

MD:-5.50 (-9.77 to -1.23)

Moderate

  1. Notes: TC Total cholesterol, TGs Triglycerides, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, FBG Fasting blood glucose, AST Aspartate aminotransferase, ALT Alanine aminotransferase
  2. CI Confidence intervals, MD Mean difference
  3. Risk of bias
  4. Inconsistency
  5. Directness
  6. Imprecision
  7. Publication Bias
  8. Other considerations